curriculum vitae mahasen ali radwan, ph.d

1 | P a g e

Curriculum Vitae Mahasen Ali Radwan, Ph.D.

Professor of Clinical Pharmacy Head of the Department of Pharmacy Practice/Clinical Pharmacy,

Faculty of Pharmacy, Egyptian Russian University

Suez road, Bader City, Cairo, 11829, Egypt Badr City, Cairo-Suez Road, Postal Code 11829

Tel.: (+2) 02 2864-3340, 2864-3342, Fax: (+2) 02 2864-3332

URL: // eru.edu.eg

1. Personal Information

First Name / Sure Name: Mahasen Ali Ibrahim Ali Radwan

Nationality: Egyptian

E-mail: [email protected]

Gender: Female

2. Education

Title of Awarded

Degree

Name of Organization

Providing Education

Principle Subject

Dates

Ph.D. College of Pharmacy,

University of Georgia,

GA, U.S.A.

Pharmacokinetics of

Disopyramide Drug

delivery system in

Dogs

March 1988

M.Sc. College of Pharmacy,

University of Georgia,

GA, U.S.A.

Pharmacokinetics

and Tissue

Distribution Studies

in Animals

August 1985

B.Sc. with honor College of Pharmacy, Cairo University, Cairo, Egypt.

Pharmacy May 1978

3. Professional Experience

Occupation

Name & Address of

Employer

Dates

Head of the department of

Pharmacy Practice/ Clinical

Pharmacy

Faculty of Pharmacy,

Egyptian Russian University

(ERU), Bader City, Cairo,

Egypt.

From To

9/2019 Present

Head of the department of

Pharmaceutics and

Pharmaceutical Technology


Egyptian Russian University (ERU), Bader City, Cairo, Egypt.

From To

12/2017 9/2019

Date of Birth: 19/02/1955

2 | P a g e

Head of the fifth year's

Control




Egypt

From To

12/2017 Present

Professor in the department of

Pharmaceutics and

Pharmaceutical Technology




Egypt

From To

9/2016 12/2017

Professor in the department

of Pharmaceutical Practice

Princess Nourah bint

Abdulrahahman University

(PNU) Riyadh, Saudi

Arabia

From To

9/2011

8/2016

Scientific Coordinator-

Foundation Year – PNU

Health Colleges

PNU Health

Colleges. Riyadh, Saudi Arabia

From To

9/2013 8/2016

Professor- Department of

Clinical Pharmacy

College of Pharmacy, King

Saud University (KSU)

Riyadh, Saudi Arabia

From To

6/2002 8/2011

Associate Professor- Department of Clinical Pharmacy




From To

12/1995 8/2002

Assistant Professor- Department of Clinical Pharmacy




From To

8/1992 12/1995

Assistant Professor, Department

of Pharmaceutics,

Albany College of Pharmacy,

Albany, NY, U.S.A.

From To

4/1989 8/1992

Research Associate (Post

Doctoral) Pharmaceutical

Research and Development,

Hoffmann-La Roche,

Nutley, NJ, U.S.A.

Pharmaceutical Research and

Development, Hoffmann-La

Roche, Nutley, NJ, U.S.A.

From To

3/1988 3/1989

Teaching Assistant

Department of Pharmaceutics,

College of Pharmacy,

University of Georgia, U.S.A.

4/1985 2/1988

Inspector Ministry of Health, Cairo, Egypt 8/1983

11/1978

6/1984

6/1982

3 | P a g e

4. Discipline

General Discipline

Biopharmaceutics and

Pharmacokinetics

Principle Subject Clinical

Pharmacokinetics

5. Professional & Technical Skills

1. July-September 2008 School of Pharmacy and Pharmaceutical Science, University of

Central Lancashire, Preston, UK. To conduct research in the area of liposomes and

niosomes (Nanoparticles) for amphotericin B oral and lung delivery with Professor

Anthony D'Emanuelle.

2. Nov10-13, 2008: “TQD (UPLC-MS/MS) Operation and Maintenance course”, Waters

education Headquarter, Manchester, England.

3. July-August 2004: Department of Pharmaceutical Technology, Free University of Berlin,

Berlin, Germany. To conduct research in the area of Solid Lipid Nanoparticles (SLN) of

amphotericin B and Cyclosporin with Professor Rainer Mueller.

6. Personal Skills

Computer Skills Self Assessment

Excellent Good Fair

Microsoft Office ✓

Language Skills

Excellent Good Fair Arabic

✓ English

✓

7. Scientific Activities

a. Publication:

1. Mohammed G. Maslub, Mahasen A. Radwan, Mina S. Mikhail, Zeyad A. Abdalla, “Could

favipiravir be an effective and safe option for the management of covid-19?” European

Journal of Biomedical and Pharmaceutical Sciences, (8)2: 13-33 2021. ISI*, [ DOI

: https://doi.org/10.17605/OSF.IO/SVPHJ ]

2. Mohammed G. Maslub and Mahasen A. Radwan, “The anticipated covid-19 vaccine will

keep the world pharmacovigilance systems very busy”, European Journal of Biomedical

and Pharmaceutical Sciences, (8) 2: 34-37, 2021 ISI*, DOI:

https://doi.org/10.17605/OSF.IO/F2SZD

3. Sitah Al Harthi, Seyed Ebrahim Alavi, Mahasen Ali Radwan, Mona Mohamed El Khatib

& Ibrahim Abdullah AlSarra “Nasal delivery of donepezil HCl loaded hydrogels for the

treatment of Alzheimer’s disease” Scientific Reports, 02 July 2019. ISI*,

https://doi.org/10.1038/s41598-019-46032-y

https://doi.org/10.17605/OSF.IO/F2SZD

4 | P a g e

4. Alanood S. Almurshedi, Mahasen Radwan, Samia Omar, Ayodele A. Alaiya, Mohamed

M. Badran, Hanaa Elsaghire, Imran Y. Saleem, Gillian A. Hutcheon “A novel pH-sensitive

liposome to trigger delivery of afatinib to cancer cells: Impact on lung cancer therapy” J.

Molecular Liquids 259: 154–166 (2018) ISI* , https://doi.org/ 10.1016/j.molliq.2018.03.024

5. Mahasen A. Radwan, Bushra T. AL-Quadeib, Mahasen A. Radwan, Lidija Sillerc,

Matthew Wright Ben Horrock “Oral administration of amphotericin B nanoparticles:

antifungal activity, bioavailability and toxicity in rats” Drug Deliv, 24 (1):40-50 (2017) ISI*,

https://doi.org/10.1080/10717544.2016.1228715

6. Bushra T. AL-Quadeib, Mahasen A. Radwan, Lidija Sillerc, Ben Horrock, Matthew Wright

“Stealth Amphotericin B Nanoparticles For Oral Drug Delivery: In Vitro Optimization”

Saudi Pharmaceutical Journal, 23 (3):290-302 (2015) ISI* ,

https://doi.org/10.1016/j.jsps.2014.11.004

7. Mahasen A. Radwan, Amal El Sayeh F. Abou el Ela, Maha A. Hassan and Dalia A. El-

Maraghy “Pharmacokinetics and Analgesic Effect and of Ketorolac Floating Delivery

System” Drug Delivery , 22(3): 320–327 (2015) ISI*,

https://doi.org/10.3109/10717544.2014.883189

8. Bushra T. AL-Quadeib, Mahasen A. Radwan, Lidija Sillerc, Elaine Mutch, Ben Horrock,

Matthew Wright and Abdulaziz Alshaer “Therapeutic Monitoring of Amphotericin B in

Saudi ICU Patients using UPLC MS/MS Assay” Biomedical Chromatography, 28 (12): 1652–

1659, (2014) ISI*, https://doi.org/10.1002/bmc.3198

9. Mahasen A. Radwan, Nayira A. Abdel Baky, Iman Y. Zaghloul , Hassan Y. Aboul‐Enein,

“Pharmacokinetics and Cardiovascular Effect of Etoricoxib in the Absence or Presence of

St. John's Wort in Rats” ArzneimittelForschun-Drug Research, 62: 313–318 (2012). ISI* ,

DOI: 10.1055/s-0042-123005

10. Mahasen A. Radwan, Esraa S. Al Taweel, Abdulrahman M. Al-Moghairi, Nouf M. Aloudah,

Muneera A. Al Babtain, Hussein S. Al-Amri “Monitoring Metformin in Cardiac Patients

Exposed to Contrast Media Using Ultra–High-Performance Liquid Chromatography Tandem

Mass-Spectrometry” Therapeutic Drug monitoring, 33:742–749 (2011). ISI*, DOI:

10.1097/FTD.0b013e318237ab03

11. Mahasen A. Radwan, Ghada A. Bawazeer, Nouf M. Aloudah, Bushra T. AlQuadeib,

Hassan Y. Aboul Enein “Determination of Free and Total Warfarin Concentrations in

Plasma Using UPLC MS/MS Assay: Application to Patient Samples” Biomedical

Chromatography, 26: 6–11 (2011). ISI , https://doi.org/10.1002/bmc.1616

12. Mahasen A. Radwan, , Bushra T. Alquadeib, Nouf M. Aloudah, Hassan Y. Aboul-Enein

“Pharmacokinetics of Ketorolac Loaded to Polyethylcyanoacrylate Nanoparticles Using

UPLC MS/MS for its Determination in Rats” International Journal of Pharmaceutics

Volume 397(1-2):173-178(2010). ISI, https://doi.org/10.1016/j.ijpharm.2010.06.035

13. Iman Y. Zaghloul, Mahasen A. Radwan, May H. Al Jaser and Ramadan Al Issa “Clinical

Efficacy and Pharmacokinetics of Antimony in Cutaneous Leishmaniasis Patients Treated

With Sodium Stibogluconate”, Journal of Clinical Pharmacology, November,

50(11):12301237(2010). ISI, https://doi.org/10.1177/0091270009347674

5 | P a g e

14. Mahasen A. Radwan, Iman Y. Zaghloul, Nayira A. Abdel Baky “Stability indicating high

performance liquid chromatographic assay for the pharmacokinetics of Cyclooxygenase

(COX-2) inhibitor etoricoxib in rats” African J. of Pharmacy & Pharmacology, 3(7):339346

(2009). http://www.academicjournals.org/ajpp

15. Nayira A. Abdel Baky, Nouf M. Al-Rasheed, Nawal M. Al-Rasheed, Iman Y Zaghloul, and

Mahasen A. Radwan “Alpha-lipoic acid and amlodipine ameliorate myocardial infarction

induced by isoproterenol in rats” International Journal of Academic Research, 1 (1): 68-77

(2009). www.ijar.lit.az

16. Mahasen A. Radwan, May H. AL Jaser, Zahra R. Al Rayes" The effects of induced diabetes

and cutaneous Leishmania infection on the pharmacokinetics of antimony in hamsters"

Annals of Tropical Medicine & Parasitology, 101 (1):1– 10 (2007). ISI,

https://doi.org/10.1179/136485907X154520

17. Iman Y. Zaghloul, Mahasen A. Radwan, Zinat H. Aly "The Effect of Chronic Cadmium

Exposure on the Pharmacokinetics of Theophylline and Ciprofloxacin in Rats" J. Trace

Elements in Medicine and Biology, 21:132-137 (2007). ISI ,

https://doi.org/10.1016/j.jtemb.2006.12.006

18. May H. AL Jaser, Mahasen A. Radwan, Iman Y. Zaghloul "Pharmacokinetics and tissue

distribution of antimony(v) after multiple intramuscular administrations in the hamster"

Saudi Pharmaceutical Journal, 14: 52-58 (2006). ISI

19. Nahla S. Barakat and Mahasen A. Radwan "In Vitro performance of carbamazepine loaded

to various molecular weights of poly (D, L - lactide - co - glycolide)"; Journal of Drug Delivery,

13(1):9-18 (2006). ISI DOI: 10.1080/10717540500308992

20. Mahasen A. Radwan, Heba H. Abdine, Bushra T. Al-Quadeb, Hassan Y. Aboul-Enein

Kenichiro Nakashima “Steroselective HPLC assay of donepezil enantiomers with UV

detection and its application to Pharmacokinetics in rats” J. Chromatography B,

830:114119 (2006). ISI, https://doi.org/10.1016/j.jchromb.2005.10.031

21. Mahasen A. Radwan, Heba H. Abdine, Hassan Y. Aboul-Enein “A Validated Chiral HPLC

Method for the Determination of Mebeverine HCl Enantiomers in Pharmaceutical

Dosage Forms and Spiked Rat Plasma” Biomedical Chromatography, 20(2):211-216

(2005). ISI, https://doi.org/10.1002/bmc.556

22. Norah O. Abanmy, Msc., Iman Y. Zaghloul, Ph.D., Mahasen A. Radwan, Ph.D. "Compatibility

of tramadol parentral injection with selected drugs and solutions"; American Journal of

Health System Pharmacy, 62:1299-1302 (2005). ISI, DOI: 10.1093/ajhp/62.12.1299

23. Nouf M. Aloudah, Mahasen A. Radwan, Nasser F. Al Omar and Sydney Jacobs "HPLC Assay

of Fluconazole and its Application to Patients with Early Septic Shock"; J. of Liquid

Chromatography & related Technologies, 28: 591–600 (2005). ISI,

https://doi.org/10.1081/JLC-200047213

24. Hassan Y. Aboul-Enein, Rajaa F. Hussein, Mahasen A. Radwan, Sameer Al-Rawithi

“Biotin dissolution from pharmaceutical dosage forms using an automated hplc system” J.

of Liquid Chromatography & related Technologies, 27:511-519 (2004). ISI,

https://doi.org/10.1081/JLC-120027622

https://doi.org/10.1016/j.jchromb.2005.10.031

6 | P a g e

25. Mahasen A. Radwan and Hassan Abu El-Enein, “In Vitro Release and Stereoselective

Disposition of Flurbiprofen Loaded to Poly(D,L-Lactide-Co-glycolide) Nanoparticles in

Rats”. Chirality, 16:119-125 (2004). ISI, https://doi.org/10.1002/chir.10314

26. Al-Jaser, MH, El-Khameesy, SU, Ghannam, MM, Al-Essa, N, Al-Saleh, FM, Al-Garawi, M,

Zaghloul, I, Radwan M, Al Mubbarak, H, Al-Zuhai, H, Al-Garawi, M and AL-Ayed,

M, “Radioactivity Concentration in Surface Soil Samples from Al-Mezahmiah Area,

Southwest of Riyadh, Kingdom of Saudi Arabia”. Egyptian J. Biophysics, 36:4, 727733

(2004).

27. Al-Jaser, MH, El-Khameesy, SU, Ghannam, MM, Al-Saleh, FM, Al-Garawi, M, Zaghloul, I,

Radwan M, Al-Garawi, M, and AL-Ayed, M, “Radioactivity of 226Ra and 40K in the ground

water around Burraydah treatment plant in the northwest of Riyadh, Saudi Arabia”.

Egyptian J. Biophysics, (2003).

28. Magda A. El-Sherbeny, Huda S. Al-Salem, Maha A. Sultan, Mahasen A. Radwan, Hassan

Farag, and Hussein I. El-Subbagh, “Synthesis, in Vitro and in Vivo Evaluation of a Delivery

System for Targeting Anticancer Drugs to the Brain” Pharmazeutische und Medizinische

Chemie, 336:445-455 (2003). ISI, https://doi.org/10.1002/ardp.200300760

29. Hassan Abu El-Enein, Rajaa F. Hussein, Mahasen A. Radwan, Ahmad Yusuf, Wijdan AL-

Ahmadi, and Sameer Al-Rawithi ”Tamsulosin dissolution from pharmaceutical dosage

forms using an automated hplc system” J. of Liquid Chromatography & related

Technologies, 26:1109-1116 (2003). ISI, https://doi.org/10.1081/JLC-120020097

30. Mahasen A. Radwan, May H. AL Jaser, Iman Y. Zaghloul, and Shaheen M. Nakeeb

"Pharmacokinetics of Zidovudine and Pentavalent Antimony After Single and Steady State

Administrations In Leishmania Infected Hamsters" Saudi Pharmaceutical Journal, 10: 113-

118 (2002). ISI,

31. Mahasen A. Radwan and Hassan Y. Aboul-Enein “The effect of various oral absorption

enhancers on the in vivo performance of insulin–loaded poly(ethylcyanoacrylate)

nanospheres in diabetic rats” Journal of microencapsulation, 19:225-235 (2002). ISI,

https://doi.org/10.1016/S0378-5173(01)00595-6

32. Mahasen A. Radwan “Enhancement of insulin – loaded polyisobutylcyanoacrylate

nanospheres absorption by sodium cholate after oral and subcutaneous administrations in

diabetic rats” Drug Development and Industrial Pharmacy, 27:981-989 (2001). ISI,

https://doi.org/10.1081/DDC-100107680

33. Mahasen A. Radwan and Hassan Y. Aboul-Enein “The effect of absorption enhancers on

the initial degradation kinetics of insulin by α-chymotrypsin” International Journal of

Pharmaceutics, 217:111-120 (2001). ISI, https://doi.org/10.1016/S0928-0987(98)00060-8

34. Mahasen A. Radwan “Preparation and in vivo evaluation of parenteral metoclopramide –

loaded poly(alkylcyanoacrylate) nanospheres in rats” Journal

of Microencapsulation18:467-477(2001). ISI,

https://doi.org/10.1080/02652040010018146

35. Mahasen A. Radwan, Iman Y. Zaghloul, Badraldin M. Al-Hadiyah, and Khalil I. AlKhamis

“The influence of fluvoxamine administration on glibenclamide pharmacokinetics after

multiple oral dosing in rats” Saudi Pharmaceutical Journal, 8: 116-121 (2000). ISI

https://doi.org/10.1016/S0378-5173(01)00595-6

https://doi.org/10.1080/02652040010018146

7 | P a g e

36. Mahasen A. Radwan "Zidovudine, diclofenac, and ketoprofen pharmacokinetic

interactions in rats" Journal Pharmacy and Pharmacology, 52:665-669 (2000). ISI,

https://doi.org/10.1211/0022357001774507

37. S. Elkheshen and M. A. Radwan ”Sustained release microspheres of metoclopramide using

poly(D,L-lactide-co-glycolide) copolymers” Journal of Microencapsulation, 17(4):425-435

(2000). ISI, https://doi.org/10.1080/026520400405688

38. Mahasen A. Radwan, Iman Y. Zaghloul, and Zinat H. Aly, “In-vivo performance of parenteral

theophylline - loaded polyisobutylcyanoacrylate nanoparticles in rats” European Journal

Pharmaceutical Science, 8:95-98 (1999). ISI, https://doi.org/10.1016/S0928-

0987(98)00060-8

39. Mahasen A. Radwan “Determination of metoclopramide in serum by HPLC assay

and its application to pharmacokinetic study in rat” Analytical Letters, 31 (14):

2397-2410 (1998). ISI, https://doi.org/10.1080/00032719808005314

40. Mahasen A. Radwan, Iman Y. Zaghloul, Ahmed I. Radwan, Zinat H. Aly, “Multiple – Dose

pharmacokinetics of long -acting oxytetracycline in Brucella Melitensis – infected sheep”,

International Journal of Pharmaceutics, 160:91-7 (1998). ISI,

https://doi.org/10.1016/S0378-5173(97)00300-1

41. Iman Y. Zaghloul and Mahasen A. Radwan “High Performance Liquid Chromatographic

Determination of Tramadol in Pharmaceutical Dosage Forms” J. of Liquid

Chromatography, 20:779-87 (1997). ISI, https://doi.org/10.1080/10826079708014142

42. Iman Y. Zaghloul, Zinat H. Aly and Mahasen A. Radwan “Effect of Ciprofloxacin on the

Hypoprothrombinemic Activity of Warfarin in Rats”, International Journal of

Pharmaceutics, 131 (2):131-6 (1996). ISI, https://doi.org/10.1016/0378-5173(95)04264-4

43. Mahasen A. Radwan, Zinat H. Aly, and Iman Y. Zaghloul, “Effect of Experimental Liver

Damage by CCL4 on the Pharmacokinetics of Zidovudine in Rats” Saudi Pharmaceutical

Journal, 3:90 - 94 (1995). ISI

44. Mahasen A. Radwan “HPLC Assay of Theophylline and Zidovudine in Rat Serum” J. of Liquid

Chromatography, 18 (16):3301-3309 (1995). ISI,

https://doi.org/10.1080/10826079508010452

45. Mahasen A. Radwan “In vitro Evaluation of Polyisobutylcyanoacrylate

Nanoparticles as a Controlled Drug Delivery System of Theophylline”, Drug

Development and Industrial Pharmacy, 21(20): 2371-75 (1995). ISI,

https://doi.org/10.3109/03639049509070875

46. Mahasen A. Radwan, James C. Price, and Randall L. Tackett, “IN VITRO Release of

Disopyramide from Cellulose Acetate Butyrate Microspheres” Drug Development and

Industrial Pharmacy, 21: 1453-62(1995). ISI,

https://doi.org/10.3109/03639049509063032

47. M. Radwan “In Vivo Screening Model for Excipients and Vehicles Used in Subcutaneous

Injections”, Drug Development and Industrial Pharmacy, 20: 2753-62 (1994). ISI,

https://doi.org/10.3109/03639049409042678

8 | P a g e

48. M.A. Radwan “Stability-Indicating HPLC Assay of Zidovudine in Extemporaneous Syrup”,

Analytical Letters, 27: 1159-1164 (1994). ISI,

https://doi.org/10.1080/00032719408000286

49. Mahasen A. Radwan, James C. Price, and Randall L.Tackett, "Analysis of Disopyramide by

HPLC with UV Detection", Analytical Letters, 20:1125-31 (1987). ISI,

https://doi.org/10.1080/00032718708064596

50. H. Won Jun and Mahasen A. Radwan, "Determination of Oxamniquine in Plasma Samples"

Analytical Letters, 18:(1985). ISI, https://doi.org/10.1080/00032718508066215

CHAPTERS

1. Mahasen A. Radwan, Nagwa H. Foda, and Omar A. Al Deeb “Mebeverine Hydrochloride”

Analytical Profiles of Drug Substances and Excipients, 25: 165-207 (1998).

2. Nagwa H. Foda, Mahasen A. Radwan, and Omar A. Al Deeb “Fluvoxamine Maleate”

Analytical Profiles of Drug Substances and Excipients, 24:165-208 (1996).

b. Supervision:

Degree Researcher Name Ph.D. Mohammed Gamal Ph.D. Alanoud Almurshidy Ph.D. Bushra AlQuadeib Ph.D. Rash Kamel

M.Sc. Zahra Alrays

M.Sc. Ola Alomran M.Sc. Maha Alderimli

M.Sc. Nouf Alouda

M.Sc. Rania Algezani

M.Sc. Safaa Almyibid

M.Sc. Esraa Altaweel

M.Sc. Leena Said

c. Conferences

Conferences

Professional Conference Organizer

“Recent Trends in Pharmaceutical Sciences” Egyptian Russian University (ERU)

43rd Annual Meeting & Exposition of the Controlled Release Society, July 17 – 20, 2016

Controlled Release Society, Washington State Convention Center in Seattle, Washington, U.S.A.

Annual Meeting, November 10-14, 2013. AAPS, San Antonio, TX, USA.

May 2009 New drugs in pharmacological research

The Joint Meeting of Britches pharmacological

Society, Dresden, Germany,

February 2009 1st International Conference on

Biotechnology

KSU, Riyadh.

2006 AAPS Annual Meeting (10/28/2006 -

11/2/2006) AAPS, San Antonio, TX, USA.

9th International Pharmaceutical Sciences

Meeting and Exposition, December 17-21, 2005

Riyadh, Saudi Arabia.

April 10-15 (2005) Worldleish 3 Sicicily, Palirmo - Italy

Annual Meeting of the American-College-of-Clinical

Pharmacy, OCT 24-27, (2004).

The American-College-of-Clinical Pharmacy,

Pharmacotherapy, USA

7th International Conference on Chemistry and its

Role in Development. April 14-17, 2003.

Mansoura & Sharm El-Sheikh, Egypt

The 1st International Congress Pharmaceutical &

Drug Industries Division National Research Centre

– Towards Safe and active Drug. March 24-26,

2003.

Pharmaceutical & Drug Industries Division National

Research Centre – Egypt

The Pharmacy Profession in the 21st Century,

October 1999.

Saudi Pharmaceutical Society, Riyadh, KSA

Sixteenth Annual Meeting on Biological Natural

Resources in Kingdom of Saudi Arabia, March

1995.

Saudi Biological Society, Sixteenth Annual Meeting,

Riyadh, KSA

American Association of Pharmaceutical

Scientists, November, 1991

American Association of Pharmaceutical Scientists,

Washington DC, USA.


October, 1989


Atlanta, USA.


November, 1988.


Orlando, Orlando, USA.

Graduate Research Association of Students in

Pharmaceutics, June, 1987.


Pharmaceutics, West Virginia, USA.


Boston, June, 1987.


Boston, USA.

http://www.controlledreleasesociety.org/MEETINGS/ANNUAL/Pages/default.aspx






http://abstracts.aapspharmaceutica.com/expoaaps06/cc/forms/attendee/index.aspx?content=speakerInfo&speakerId=61







November, 1986.

1. American Association of Pharmaceutical Scientists,

Washington DC, USA.


Pharmaceutics, July, 1985.


Pharmaceutics, New Jersey, USA.

10 P a g e

8. Trainings & Workshops

Title of Training or Workshop

Name of Organization Providing Training

Date

Notes

“Professional Development” program, 12 hours,

Center for Excellence in Teaching and Learning. Pricess Nourah bint Abdulrahman University.

April 5 & 12, 2016.

“Professional Portfolio” program, 4 hours,

Center for Excellence in Teaching and Learning. Pricess Nourah bint Abdulrahman

Feb. 25, 2016

“Applying Standards of Quality Assurance and Academic Accreditation”

Dr. Hannan Algadhi, Pricess Nourah bint Abdulrahman University.

Dec 29,2014

“Quality Assurance and Academic Accreditation”

Dr. H. AlOlyan, Pricess Nourah bint

Abdulrahman University.

Dec 7, 2011

: “Teaching how to teach” Partners Harvard Medical

International (Faculty development

Program) Novotel Hotel, Riyadh.

Nov 30-Dec 2, 2010

“Motivating student, active learning and assessing student learning Worhshop”

by Experts from USA given in

Almalaz Campus (Faculty

development Program) Riyadh. KSA

Sept 19-21, 2010

“Parametric and Nonparametric SPSS” training course.

Faculty development Program) in

Alisha Campus, Riyadh.

Feb 2-4, 2009

“Reviewing and improving your teaching”

Faculty development Program),

Riyadh.

Dec 2-3, 2008

9. Membership of Professional Associations

1. 1986-Present: Member of the American Association of Pharmaceutical Scientists

(AAPS).

2. 1994-Present: Member of the Saudi Pharmaceutical Association (SPHA).

3. 1987-Present: Controlled Release Society (CRS)

10. Awards From ERU (2016-2019)

1. Sitah Al Harthi, Seyed Ebrahim Alavi, Mahasen Ali Radwan, Mona Mohamed El Khatib & Ibrahim

Abdullah AlSarra “Nasal delivery of donepezil HCl loaded hydrogels for the treatment of Alzheimer’s

disease” Scientific Reports, 02 July 2019. ISI*

2. Mahasen A. Radwan, Bushra T. AL-Quadeib, Mahasen A. Radwan, Lidija Sillerc, Matthew Wright Ben

Horrock “Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and

toxicity in rats” Drug Deliv, 24 (1):40-50 (2017) ISI*

From PNU (2016)

1. Bushra T. AL-Quadeib, Mahasen A. Radwan, Lidija Sillerc, Ben Horrock, Matthew Wright “Stealth

Amphotericin B Nanoparticles For Oral Drug Delivery: In Vitro Optimization” Saudi Pharmaceutical Journal,

23 (3):290-302 (2015) ISI*

2. Mahasen A. Radwan, Amal El Sayeh F. Abou el Ela, Maha A. Hassan and Dalia A. El- Maraghy

“Pharmacokinetics and Analgesic Effect and of Ketorolac Floating Delivery System”

Drug Delivery , 22(3): 320–327 (2015) ISI*

3. Bushra T. AL-Quadeib, Mahasen A. Radwan, Lidija Sillerc, Elaine Mutch, Ben Horrock,

Matthew Wright and Abdulaziz Alshaer “Therapeutic Monitoring of Amphotericin B in Saudi ICU Patients

using UPLC MS/MS Assay” Biomedical Chromatography, 28 (12): 1652–1659, (2014) ISI*

4. Mahasen A. Radwan, Nayira A. Abdel Baky, Iman Y. Zaghloul , Hassan Y. Aboul‐Enein, “Pharmacokinetics

and Cardiovascular Effect of Etoricoxib in the Absence or Presence of St. John's Wort in Rats”

ArzneimittelForschun-Drug Research, 62: 313–318 (2012). ISI*

From KSU (2011 & 2015)

1. Alanood S. Almurshedi, Mahasen Radwan, Samia Omar, Ayodele A. Alaiya, Mohamed M.

Badran, Hanaa Elsaghire, Imran Y. Saleem, Gillian A. Hutcheon “A novel pH-sensitive

liposome to trigger delivery of afatinib to cancer cells: Impact on lung cancer therapy” J.

Molecular Liquids 259: 154–166 (2018) ISI*

2. Mahasen A. Radwan, Amal El Sayeh F. Abou el Ela, Maha A. Hassan and Dalia A. El-

Maraghy “Pharmacokinetics and Analgesic Effect and of Ketorolac Floating Delivery System”

Drug Delivery , 22(3): 320–327 (2015). ISI*

3. Mahasen A. Radwan, , Bushra T. Alquadeib, Nouf M. Aloudah, Hassan Y. Aboul Enein“Pharmacokinetics

of Ketorolac Loaded to Polyethylcyanoacrylate Nanoparticles

Using UPLC MS/MS for its Determination in Rats” International Journal of Pharmaceutics

Volume 397(1-2):173-178(2010) ISI

4. Zaghloul IY, Radwan MA, Al Jaser MH, Al Issa R “Clinical Efficacy and

Pharmacokinetics of Antimony in Cutaneous Leishmaniasis Patients Treated With Sodium

Stibogluconate”: Journal of Clinical Pharmacology, 50(11):1230-1237 (2010).

5. Mahasen A. Radwan, Iman Y. Zaghloul, Nayira A. Abdel Baky “Stability indicating high performance liquid chromatographic assay for the pharmacokinetics of Cyclooxygenase (COX-2) inhibitor etoricoxib in rats” African J. of Pharmacy & Pharmacology, 3(7):339346 (2009). ISI

I certify that the information provided in this curriculum vitae is accurate.

Name

Mahasen Ali Radwan

Signature

Date

4/2/2021

12 | P a g e

curriculum vitae mahasen ali radwan, ph.d

Documents